共识综述:改善穿越血脑屏障递送策略包括聚焦超声
中枢神经系统肿瘤药物递送受血脑屏障限制,本共识综述汇总利用天然转运机制或绕过血脑屏障的多项技术,重点阐述激光间质热治疗与低强度聚焦超声暂时增加血脑屏障通透性的优势、不足与主要进展,指出多数进展仍限于动物研究,但转化临床试验逐渐增多并将在未来几年出结果。
要点
- 低强度聚焦超声可暂时增加血脑屏障通透性以助化疗药入脑,是本文重点。
- 激光间质热治疗亦为暂时增加血脑屏障通透性的新技术之一。
- 多数技术进展仍来自动物研究,转化临床试验结果将在未来几年公布。
核心结论
- 综述认为低强度聚焦超声是允许化疗药物穿越血脑屏障的主要研究领域,多数进展仍限于动物研究,但转化临床试验逐渐增多并将在未来几年出结果。
研究设计与样本
- 共识综述,概述利用天然转运机制或绕过血脑屏障的多项技术以及激光间质热治疗和低强度聚焦超声暂时增加血脑屏障通透性的优势、不足与主要进展。
局限性
- 原文指出多数进展仍限于动物研究。
- 原文指出转化临床试验逐渐增多并将在未来几年出结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Drug delivery to the central nervous system (CNS) has been a major challenge for CNS tumors due to the impermeability of the blood-brain barrier (BBB). There has been a multitude of techniques aimed at overcoming the BBB obstacle aimed at utilizing natural transport mechanisms or bypassing the BBB which we review here. Another approach that has generated recent interest in the recently published literature is to use new technologies (Laser Interstitial Thermal Therapy, LITT; or Low-Intensity Focused Ultrasound, LIFU) to temporarily increase BBB permeability. This review overviews the advantages, disadvantages, and major advances of each method. LIFU has been a major area of research to allow for chemotherapeutics to cross the BBB which has a particular emphasis in this review. While most of the advances remain in animal studies, there are an increasing number of translational clinical trials that will have results in the next few years.
引用
- Piper K, Kumar JI, Domino J, et al. Consensus review on strategies to improve delivery across the blood-brain barrier including focused ultrasound. Neuro Oncol. 2024. PMID: 38770775. doi:10.1093/neuonc/noae087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。